chevron_leftBack
As of 24 April 2025, Wuhan Easy Diagnosis Biomedicine Co.,Ltd. has a market cap of $523.54M USD, ranking #11655 globally and #3686 in China. It ranks #1134 in the Healthcare sector, and #124 in the Medical Devices industry.
Key Stats
Market Cap
$523.54MUSD
3.82B CNY
Enterprise Value
$481.28MUSD
3.51B CNY
Revenue (TTM)
$47.92MUSD
349.23M CNY
EBITDA (TTM)
-$11.93MUSD
-86.95M CNY
Net Income (TTM)
$1.45MUSD
10.56M CNY
EBITDA Margin
-25%
Profit Margin
3%
PE Ratio
361.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Chen Li Li
open_in_new
Employees
1,063
Founded
2008
Website
mdeasydiagnosis.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.5% | -1.8% | -9.8% | -3.4% | -4.9% | -14% |
Upcoming Earnings
Earnings Date
Fri, Apr 25
Tomorrow
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002932
武汉明德生物科技股份有限公司 Class A
ISIN: CNE1000033Q7
Shares Out.:
Shares Outstanding:
222.973M1
Shares Float:
186.651M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
17.15 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer. The company also provides emergency and critical illness information solutions, including software, hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, infectious diseases, prenatal and postnatal care, health examination, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection, etc. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.
